Raghav Shroff

Technologies

• Bacterial reagents: stable, low-cost, readily available reagents with no purification requirements
• Engineered RNA polymerases and capping enzymes for the expression of 7‑methylguanylate capped RNA
• Human enzyme-mediated depletion of serine in cancer
• Engineered prefusion-stabilized RSV fusion proteins and nucleic acids for enhanced vaccines and diagnostics